Title:
A THERAPEUTIC AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS
Document Type and Number:
WIPO Patent Application WO/2023/114912
Kind Code:
A3
Abstract:
The present disclosure provides a recombinant vector from an attenuated rabies virus comprising a nucleotide sequence encoding at least one CCHFV glycoprotein and at least one mucin like domain. The disclosure further provides a method for conditioning an immune response with said recombinant virus vector incorporated in said virus virion.
Inventors:
SCHNELL MATTHIAS JOHANNES (US)
SCHER GABRIELLE (US)
SCHER GABRIELLE (US)
Application Number:
PCT/US2022/081661
Publication Date:
August 03, 2023
Filing Date:
December 15, 2022
Export Citation:
Assignee:
UNIV JEFFERSON (US)
International Classes:
C07K14/175; A61K39/12; C12N7/00; C12N15/86
Domestic Patent References:
| WO2021178886A1 | 2021-09-10 | |||
| WO2020010474A1 | 2020-01-16 |
Foreign References:
| US20110086768A1 | 2011-04-14 |
Attorney, Agent or Firm:
DOYLE, Kathryn et al. (US)
Download PDF:
Previous Patent: FUEL CELL COMPONENT INCLUDING POLYTETRAFLUOROETHYLENE FILM BONDED TO GRAPHITE
Next Patent: CATALYST DECONTAMINATION PROCESS
Next Patent: CATALYST DECONTAMINATION PROCESS